M. Magnet

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Enrico Amico, Philippe Allain, Mark Mühlau, 2017, The Lancet. Neurology.

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY

Alexander Münchau, Caroline Hallam, Andrea Ciarmiello, 2011, PLoS currents.

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

R. Barker, R. Reilmann, B. Landwehrmeyer, 2011, The Lancet Neurology.

Cabergoline in Huntington's disease: the first case report

R. Bonelli, H. Kapfhammer, M. Magnet, 2006, Acta neurologica Scandinavica.

NMDA receptor gene variations as modifiers in Huntington disease: a replication study

J. Schiefer, R. Barker, R. Reilmann, 2011, PLoS currents.

Amantadine in the Akinetic-Rigid Variant of Huntington's Disease

R. Bonelli, H. Kapfhammer, M. Magnet, 2004, The Annals of pharmacotherapy.

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

R. Reilmann, B. Landwehrmeyer, A. Rosser, 2011, The Lancet Neurology.